Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥ 32 33 32 33 O
1,500 34 39 34 39 B-lower_bound
/ 39 40 39 40 I-lower_bound
ul 40 42 40 42 I-lower_bound
, 42 43 42 43 O
platelets 44 53 44 53 B-clinical_variable
≥ 54 55 54 55 O
150,000 56 63 56 63 B-lower_bound
/ 63 64 63 64 I-lower_bound
ul 64 66 64 66 I-lower_bound

Acute 0 5 67 72 B-chronic_disease
hepatitis 6 15 73 82 I-chronic_disease

Age 0 3 83 86 B-age
≥ 4 5 87 88 O
18 6 8 89 91 B-lower_bound
years 9 14 92 97 I-lower_bound

Bilirubin 0 9 98 107 B-clinical_variable
≤ 10 11 108 109 O
1.5 12 15 110 113 B-upper_bound
x 16 17 114 115 I-upper_bound
ULN 18 21 116 119 I-upper_bound
, 21 22 119 120 O
aspartate 23 32 121 130 B-clinical_variable
aminotransferase 33 49 131 147 I-clinical_variable
( 50 51 148 149 I-clinical_variable
AST 51 54 149 152 I-clinical_variable
) 54 55 152 153 I-clinical_variable
or 56 58 154 156 I-clinical_variable
alanine 59 66 157 164 I-clinical_variable
aminotransferase 67 83 165 181 I-clinical_variable
( 84 85 182 183 I-clinical_variable
ALT 85 88 183 186 I-clinical_variable
) 88 89 186 187 I-clinical_variable
≤ 90 91 188 189 O
2.5 92 95 190 193 B-upper_bound
x 96 97 194 195 I-upper_bound
ULN 98 101 196 199 I-upper_bound

Creatinine 0 10 200 210 B-clinical_variable
≤ 11 12 211 212 O
1.5 13 16 213 216 B-upper_bound
x 17 18 217 218 I-upper_bound
institutional 19 32 219 232 I-upper_bound
upper 33 38 233 238 I-upper_bound
limit 39 44 239 244 I-upper_bound
of 45 47 245 247 I-upper_bound
normal 48 54 248 254 I-upper_bound
( 55 56 255 256 I-upper_bound
ULN 56 59 256 259 I-upper_bound
) 59 60 259 260 I-upper_bound

Current 0 7 261 268 O
active 8 14 269 275 B-chronic_disease
infection 15 24 276 285 I-chronic_disease
requiring 25 34 286 295 O
systemic 35 43 296 304 B-treatment
antibiotic 44 54 305 315 I-treatment
or 55 57 316 318 O
antifungal 58 68 319 329 B-treatment
therapy 69 76 330 337 I-treatment

Eastern 0 7 338 345 B-clinical_variable
Cooperative 8 19 346 357 I-clinical_variable
Oncology 20 28 358 366 I-clinical_variable
Group 29 34 367 372 I-clinical_variable
( 35 36 373 374 I-clinical_variable
ECOG 36 40 374 378 I-clinical_variable
) 40 41 378 379 I-clinical_variable
performance 42 53 380 391 I-clinical_variable
status 54 60 392 398 I-clinical_variable
0 61 62 399 400 B-lower_bound
- 62 63 400 401 O
2 63 64 401 402 B-upper_bound

Histologically 0 14 403 417 O
or 15 17 418 420 O
cytologically 18 31 421 434 O
confirmed 32 41 435 444 O
, 41 42 444 445 O
primary 43 50 446 453 O
or 51 53 454 456 O
recurrent 54 63 457 466 O
, 63 64 466 467 O
head 65 69 468 472 B-cancer
and 70 73 473 476 I-cancer
neck 74 78 477 481 I-cancer
squamous 79 87 482 490 I-cancer
cell 88 92 491 495 I-cancer
carcinoma 93 102 496 505 I-cancer
, 102 103 505 506 O
including 104 113 507 516 O
variants 114 122 517 525 O
. 122 123 525 526 O
Patients 124 132 527 535 O
must 133 137 536 540 O
have 138 142 541 545 O
at 143 145 546 548 O
least 146 151 549 554 O
one 152 155 555 558 B-lower_bound
measureable 156 167 559 570 O
lesion 168 174 571 577 O
in 175 177 578 580 O
accordance 178 188 581 591 O
with 189 193 592 596 O
RECIST 194 200 597 603 O
1.1 201 204 604 607 O
( 205 206 608 609 O
tumor 206 211 609 614 B-clinical_variable
diameter 212 220 615 623 I-clinical_variable
≥ 221 222 624 625 O
1 223 224 626 627 B-lower_bound
cm 225 227 628 630 I-lower_bound
; 227 228 630 631 O
short 229 234 632 637 B-clinical_variable
- 234 235 637 638 I-clinical_variable
axis 235 239 638 642 I-clinical_variable
lymph 240 245 643 648 I-clinical_variable
node 246 250 649 653 I-clinical_variable
diameter 251 259 654 662 I-clinical_variable
≥ 260 261 663 664 O
1.5 262 265 665 668 B-lower_bound
cm 266 268 669 671 I-lower_bound
) 268 269 671 672 O
OR 270 272 673 675 O
by 273 275 676 678 O
caliper 276 283 679 686 O
measurement 284 295 687 698 O
( 296 297 699 700 O
tumor 297 302 700 705 O
diameter 303 311 706 714 O
≥ 312 313 715 716 O
1 314 315 717 718 O
cm 316 318 719 721 O
) 318 319 721 722 O
. 319 320 722 723 O
Any 321 324 724 727 O
diagnostic 325 335 728 738 O
pretreatment 336 348 739 751 B-treatment
biopsy 349 355 752 758 I-treatment
sample 356 362 759 765 O
is 363 365 766 768 O
acceptable 366 376 769 779 O
including 377 386 780 789 O
fine 387 391 790 794 B-treatment
needle 392 398 795 801 I-treatment
aspiration 399 409 802 812 I-treatment
( 410 411 813 814 I-treatment
FNA 411 414 814 817 I-treatment
) 414 415 817 818 I-treatment

History 0 7 819 826 O
of 8 10 827 829 O
thromboembolic 11 25 830 844 B-chronic_disease
event 26 31 845 850 I-chronic_disease
or 32 34 851 853 O
other 35 40 854 859 O
condition 41 50 860 869 O
currently 51 60 870 879 O
requiring 61 70 880 889 O
anticoagulation 71 86 890 905 B-treatment
with 87 91 906 910 I-treatment
warfarin 92 100 911 919 I-treatment
( 101 102 920 921 O
coumadin 102 110 921 929 B-treatment
) 110 111 929 930 O

Patients 0 8 931 939 O
who 9 12 940 943 O
are 13 16 944 947 O
treated 17 24 948 955 O
with 25 29 956 960 O
low 30 33 961 964 B-treatment
molecular 34 43 965 974 I-treatment
weight 44 50 975 981 I-treatment
heparin 51 58 982 989 I-treatment
or 59 61 990 992 O
fondaparinux 62 74 993 1005 B-treatment
are 75 78 1006 1009 O
eligible 79 87 1010 1018 O

Pregnancy 0 9 1019 1028 B-pregnancy

Primary 0 7 1029 1036 B-cancer
tumors 8 14 1037 1043 I-cancer
of 15 17 1044 1046 O
any 18 21 1047 1050 O
head 22 26 1051 1055 O
and 27 30 1056 1059 O
neck 31 35 1060 1064 O
( 36 37 1065 1066 O
oral 37 41 1066 1070 O
cavity 42 48 1071 1077 O
, 48 49 1077 1078 O
oropharynx 50 60 1079 1089 O
, 60 61 1089 1090 O
hypopharynx 62 73 1091 1102 O
, 73 74 1102 1103 O
or 75 77 1104 1106 O
larynx 78 84 1107 1113 O
) 84 85 1113 1114 O
site 86 90 1115 1119 O
will 91 95 1120 1124 O
be 96 98 1125 1127 O
included 99 107 1128 1136 O

Prior 0 5 1137 1142 B-treatment
therapy 6 13 1143 1150 I-treatment
for 14 17 1151 1154 O
head 18 22 1155 1159 B-cancer
and 23 26 1160 1163 I-cancer
neck 27 31 1164 1168 I-cancer
cancer 32 38 1169 1175 I-cancer
is 39 41 1176 1178 O
allowed 42 49 1179 1186 O
, 49 50 1186 1187 O
and 51 54 1188 1191 O
the 55 58 1192 1195 O
number 59 65 1196 1202 O
of 66 68 1203 1205 O
treatments 69 79 1206 1216 O
is 80 82 1217 1219 O
not 83 86 1220 1223 O
limited 87 94 1224 1231 O
. 94 95 1231 1232 O
However 96 103 1233 1240 O
, 103 104 1240 1241 O
any 105 108 1242 1245 O
systemic 109 117 1246 1254 B-treatment
therapy 118 125 1255 1262 I-treatment
should 126 132 1263 1269 O
have 133 137 1270 1274 O
been 138 142 1275 1279 O
completed 143 152 1280 1289 O
at 153 155 1290 1292 O
least 156 161 1293 1298 O
30 162 164 1299 1301 B-lower_bound
days 165 169 1302 1306 I-lower_bound
prior 170 175 1307 1312 I-lower_bound
to 176 178 1313 1315 O
study 179 184 1316 1321 O
enrollment 185 195 1322 1332 O
. 195 196 1332 1333 O
Any 197 200 1334 1337 O
radiation 201 210 1338 1347 B-treatment
to 211 213 1348 1350 O
the 214 217 1351 1354 O
head 218 222 1355 1359 O
and 223 226 1360 1363 O
neck 227 231 1364 1368 O
should 232 238 1369 1375 O
have 239 243 1376 1380 O
been 244 248 1381 1385 O
completed 249 258 1386 1395 O
at 259 261 1396 1398 O
least 262 267 1399 1404 O
30 268 270 1405 1407 O
days 271 275 1408 1412 O
prior 276 281 1413 1418 O
to 282 284 1419 1421 O
study 285 290 1422 1427 O
enrollment 291 301 1428 1438 O
. 301 302 1438 1439 O
Palliative 303 313 1440 1450 B-treatment
radiation 314 323 1451 1460 I-treatment
outside 324 331 1461 1468 O
of 332 334 1469 1471 O
the 335 338 1472 1475 O
head 339 343 1476 1480 O
and 344 347 1481 1484 O
neck 348 352 1485 1489 O
does 353 357 1490 1494 O
not 358 361 1495 1498 O
require 362 369 1499 1506 O
a 370 371 1507 1508 O
washout 372 379 1509 1516 O

Prisoners 0 9 1517 1526 O
or 10 12 1527 1529 O
subjects 13 21 1530 1538 O
who 22 25 1539 1542 O
are 26 29 1543 1546 O
compulsorily 30 42 1547 1559 O
detained 43 51 1560 1568 O
( 52 53 1569 1570 O
involuntarily 53 66 1570 1583 O
incarcerated 67 79 1584 1596 O
) 79 80 1596 1597 O
for 81 84 1598 1601 O
treatment 85 94 1602 1611 B-treatment
of 95 97 1612 1614 O
either 98 104 1615 1621 O
a 105 106 1622 1623 O
psychiatric 107 118 1624 1635 O
or 119 121 1636 1638 O
physical 122 130 1639 1647 O
( 131 132 1648 1649 O
e.g. 132 136 1649 1653 O
, 136 137 1653 1654 O
infectious 138 148 1655 1665 O
) 148 149 1665 1666 O
illness 150 157 1667 1674 O

Strong 0 6 1675 1681 O
CYP3A4 7 13 1682 1688 B-treatment
inhibitors 14 24 1689 1699 I-treatment
: 24 25 1699 1700 O
( 26 27 1701 1702 O
Patients 27 35 1702 1710 O
must 36 40 1711 1715 O
discontinue 41 52 1716 1727 O
drug 53 57 1728 1732 O
7 58 59 1733 1734 O
days 60 64 1735 1739 O
prior 65 70 1740 1745 O
to 71 73 1746 1748 O
starting 74 82 1749 1757 O
ruxolitinib 83 94 1758 1769 B-treatment
) 94 95 1769 1770 O
, 95 96 1770 1771 O
including 97 106 1772 1781 O
but 107 110 1782 1785 O
not 111 114 1786 1789 O
limited 115 122 1790 1797 O
to 123 125 1798 1800 O
boceprevir 126 136 1801 1811 B-treatment
, 136 137 1811 1812 O
clarithromycin 138 152 1813 1827 B-treatment
, 152 153 1827 1828 O
conivaptan 154 164 1829 1839 B-treatment
, 164 165 1839 1840 O
indinavir 166 175 1841 1850 B-treatment
, 175 176 1850 1851 O
itraconazole 177 189 1852 1864 B-treatment
, 189 190 1864 1865 O
ketoconazole 191 203 1866 1878 B-treatment
, 203 204 1878 1879 O
lopinavir 205 214 1880 1889 B-treatment
, 214 215 1889 1890 O
mibefradil 216 226 1891 1901 B-treatment
, 226 227 1901 1902 O
nefazodone 228 238 1903 1913 B-treatment
, 238 239 1913 1914 O
nelfinavir 240 250 1915 1925 B-treatment
, 250 251 1925 1926 O
posaconazole 252 264 1927 1939 B-treatment
, 264 265 1939 1940 O
ritonavir 266 275 1941 1950 B-treatment
, 275 276 1950 1951 O
saquinavir 277 287 1952 1962 B-treatment
, 287 288 1962 1963 O
telaprevir 289 299 1964 1974 B-treatment
, 299 300 1974 1975 O
telithromycin 301 314 1976 1989 B-treatment
, 314 315 1989 1990 O
or 316 318 1991 1993 O
voriconazole 319 331 1994 2006 B-treatment
. 331 332 2006 2007 O
In 333 335 2008 2010 O
addition 336 344 2011 2019 O
, 344 345 2019 2020 O
patients 346 354 2021 2029 O
will 355 359 2030 2034 O
be 360 362 2035 2037 O
instructed 363 373 2038 2048 O
to 374 376 2049 2051 O
avoid 377 382 2052 2057 O
grapefruit 383 393 2058 2068 O
or 394 396 2069 2071 O
grapefruit 397 407 2072 2082 O
juice 408 413 2083 2088 O
, 413 414 2088 2089 O
starfruit 415 424 2090 2099 O
, 424 425 2099 2100 O
or 426 428 2101 2103 O
seville 429 436 2104 2111 O
oranges 437 444 2112 2119 O

Surgical 0 8 2120 2128 B-treatment
resection 9 18 2129 2138 I-treatment
of 19 21 2139 2141 I-treatment
head 22 26 2142 2146 I-treatment
and 27 30 2147 2150 I-treatment
neck 31 35 2151 2155 I-treatment
must 36 40 2156 2160 O
be 41 43 2161 2163 O
planned 44 51 2164 2171 O
, 51 52 2171 2172 O
either 53 59 2173 2179 O
as 60 62 2180 2182 O
primary 63 70 2183 2190 B-treatment
treatment 71 80 2191 2200 I-treatment
or 81 83 2201 2203 O
salvage 84 91 2204 2211 B-treatment
. 91 92 2211 2212 O
Patients 93 101 2213 2221 O
must 102 106 2222 2226 O
undergo 107 114 2227 2234 O
research 115 123 2235 2243 B-treatment
biopsy 124 130 2244 2250 I-treatment
prior 131 136 2251 2256 O
to 137 139 2257 2259 O
receiving 140 149 2260 2269 O
drug 150 154 2270 2274 O

Treatment 0 9 2275 2284 O
with 10 14 2285 2289 O
a 15 16 2290 2291 O
non 17 20 2292 2295 O
- 20 21 2295 2296 O
approved 21 29 2296 2304 O
or 30 32 2305 2307 O
investigational 33 48 2308 2323 O
drug 49 53 2324 2328 O
within 54 60 2329 2335 O
30 61 63 2336 2338 B-upper_bound
days 64 68 2339 2343 I-upper_bound
prior 69 74 2344 2349 I-upper_bound
to 75 77 2350 2352 O
Day 78 81 2353 2356 O
1 82 83 2357 2358 O
of 84 86 2359 2361 O
study 87 92 2362 2367 O
treatment 93 102 2368 2377 O

Women 0 5 2378 2383 B-gender
( 6 7 2384 2385 O
patients 7 15 2385 2393 O
or 16 18 2394 2396 O
partners 19 27 2397 2405 O
of 28 30 2406 2408 O
male 31 35 2409 2413 B-gender
patients 36 44 2414 2422 I-gender
) 44 45 2422 2423 O
of 46 48 2424 2426 O
childbearing 49 61 2427 2439 O
potential 62 71 2440 2449 O
( 72 73 2450 2451 O
WOCBP 73 78 2451 2456 O
) 78 79 2456 2457 O
must 80 84 2458 2462 O
practice 85 93 2463 2471 B-contraception_consent
acceptable 94 104 2472 2482 I-contraception_consent
methods 105 112 2483 2490 I-contraception_consent
of 113 115 2491 2493 I-contraception_consent
birth 116 121 2494 2499 I-contraception_consent
control 122 129 2500 2507 I-contraception_consent
to 130 132 2508 2510 O
prevent 133 140 2511 2518 O
pregnancy 141 150 2519 2528 B-pregnancy
. 150 151 2528 2529 O
All 152 155 2530 2533 O
WOCBP 156 161 2534 2539 O
must 162 166 2540 2544 O
have 167 171 2545 2549 O
a 172 173 2550 2551 O
negative 174 182 2552 2560 B-pregnancy
pregnancy 183 192 2561 2570 I-pregnancy
test 193 197 2571 2575 O
within 198 204 2576 2582 O
4 205 206 2583 2584 B-upper_bound
weeks 207 212 2585 2590 I-upper_bound
prior 213 218 2591 2596 I-upper_bound
to 219 221 2597 2599 O
registration 222 234 2600 2612 O
, 234 235 2612 2613 O
and 236 239 2614 2617 O
this 240 244 2618 2622 O
must 245 249 2623 2627 O
be 250 252 2628 2630 O
repeated 253 261 2631 2639 O
within 262 268 2640 2646 O
72 269 271 2647 2649 B-upper_bound
hours 272 277 2650 2655 I-upper_bound
prior 278 283 2656 2661 I-upper_bound
to 284 286 2662 2664 O
first 287 292 2665 2670 O
receiving 293 302 2671 2680 O
ruxolitinib 303 314 2681 2692 B-treatment

Women 0 5 2693 2698 B-gender
of 6 8 2699 2701 O
childbearing 9 21 2702 2714 O
potential 22 31 2715 2724 O
( 32 33 2725 2726 O
WOCBP 33 38 2726 2731 O
) 38 39 2731 2732 O
must 40 44 2733 2737 O
have 45 49 2738 2742 O
a 50 51 2743 2744 O
negative 52 60 2745 2753 B-pregnancy
serum 61 66 2754 2759 I-pregnancy
pregnancy 67 76 2760 2769 I-pregnancy
test 77 81 2770 2774 O
( 82 83 2775 2776 O
sensitivity 83 94 2776 2787 B-clinical_variable
≤ 95 96 2788 2789 O
25 97 99 2790 2792 B-upper_bound
human 100 105 2793 2798 B-clinical_variable
chorionic 106 115 2799 2808 I-clinical_variable
gonadotropin 116 128 2809 2821 I-clinical_variable
( 129 130 2822 2823 I-clinical_variable
HCG 130 133 2823 2826 I-clinical_variable
) 133 134 2826 2827 I-clinical_variable
IU 135 137 2828 2830 I-clinical_variable
/ 137 138 2830 2831 I-clinical_variable
L 138 139 2831 2832 I-clinical_variable
) 139 140 2832 2833 O
within 141 147 2834 2840 O
4 148 149 2841 2842 B-upper_bound
weeks 150 155 2843 2848 I-upper_bound
prior 156 161 2849 2854 I-upper_bound
to 162 164 2855 2857 O
registration 165 177 2858 2870 O
and 178 181 2871 2874 O
will 182 186 2875 2879 O
be 187 189 2880 2882 O
repeated 190 198 2883 2891 O
within 199 205 2892 2898 O
72 206 208 2899 2901 B-upper_bound
hours 209 214 2902 2907 I-upper_bound
prior 215 220 2908 2913 I-upper_bound
to 221 223 2914 2916 O
the 224 227 2917 2920 O
start 228 233 2921 2926 O
of 234 236 2927 2929 O
study 237 242 2930 2935 O
drug 243 247 2936 2940 O
administration 248 262 2941 2955 O

